Psychiatric Clinical Trials Analytics

Who this is for

Clinical research groups, sponsors, academic teams, and digital or therapeutic programs working on psychiatric interventions, behavioral health outcomes, or trial-adjacent evidence.

Problems Keystone helps solve

• Clarifying endpoints, outcomes, and analysis choices before results are interpreted.
• Connecting symptom scales, functional outcomes, treatment context, and clinical meaning.
• Reviewing trial data narratives for coherence and appropriate caveats.
• Translating complex psychiatric trial questions for technical or non-specialist collaborators.

Example questions clients bring

• Are our endpoints aligned with the clinical question and intervention mechanism?
• How should we think about response, remission, durability, function, or subgroup effects?
• What exploratory analyses are reasonable, and what would be overinterpretation?
• How should trial findings be communicated to scientific, clinical, or product audiences?

Methods and capabilities

• Endpoint and outcome review.
• Trial analysis planning support.
• Interpretation of symptom, function, and longitudinal measures.
• Scientific communication and evidence-positioning review.

Typical deliverables

• Trial analytics memo.
• Endpoint and outcome framework.
• Analysis-plan critique.
• Results-interpretation brief.
• Manuscript, poster, or stakeholder-summary support.

Relevant research foundation

This service area draws on psychiatry, clinical trials experience, translational neuroscience, behavioral health outcome interpretation, and research communication.

What Keystone does not do

Keystone does not act as a contract research organization, replace a trial statistician or regulatory team, or make efficacy claims unsupported by the study design.